Janney Montgomery Scott
ITCI

Janney Montgomery Scott’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Janney Montgomery Scott’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,191
Closed -$421K – 2847
2025
Q1 		$421K Sell
3,191
-125
-4% -$15.6K ﹤0.01% 2107
2024
Q4 		$277K Sell
3,316
-66
-2% -$5.42K ﹤0.01% 2357
2024
Q3 		$247K Sell
3,382
-74
-2% -$5.56K ﹤0.01% 2408
2024
Q2 		$237K Sell
3,456
-84
-2% -$5.83K ﹤0.01% 2353
2024
Q1 		$245K Sell
3,540
-89
-2% -$6.12K ﹤0.01% 2456
2023
Q4 		$260K Buy
+3,629
New +$209K ﹤0.01% 2312
2023
Q3 		– Sell
-3,621
Closed -$229K – 2785
2023
Q2 		$229K Buy
+3,621
New +$226K ﹤0.01% 2387
2022
Q3 		– Sell
-3,668
Closed -$203K – 2626
2022
Q2 		$203K Hold
3,668
– – ﹤0.01% 2141
2022
Q1 		$224K Sell
3,668
-489
-12% -$25.4K ﹤0.01% 2027
2021
Q4 		$218K Buy
+4,157
New +$175K ﹤0.01% 2186
2020
Q1 		– Sell
-6,787
Closed -$233K – 2121
2019
Q4 		$233K Buy
+6,787
New +$81.5K ﹤0.01% 1845

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Janney Montgomery Scott's ITCI Position: Q2 2025 in Review

Janney Montgomery Scott sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 3,191 shares — an estimated $421K sold.

Janney Montgomery Scott first reported a position in ITCI in Q4 2019 and held it in 11 quarters. The position peaked at $421K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Janney Montgomery Scott reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Janney Montgomery Scott sold 3,191 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $421K.
  • Janney Montgomery Scott first reported a position in Intra-Cellular Therapies Inc. in Q4 2019 and held it in 11 quarters.
  • Janney Montgomery Scott's Intra-Cellular Therapies Inc. position peaked at $421K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Janney Montgomery Scott's 13F filing for Q2 2025, filed 17 Jul 2025.